These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 427008)

  • 1. Plasma prolactin levels before and during propranolol treatment in chronic schizophrenia.
    Wilson JD; King DJ; Sheridan B
    Br J Clin Pharmacol; 1979 Mar; 7(3):313-4. PubMed ID: 427008
    [No Abstract]   [Full Text] [Related]  

  • 2. Some clinical and metabolic aspects of propranolol in chronic schizophrenia.
    King DJ; Turkson SN; Liddle J; Kinney CD
    Br J Psychiatry; 1980 Nov; 137():458-68. PubMed ID: 7008891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolactin response and extrapyramidal side effects during propranolol and neuroleptic drugs treatment in chronic schizophrenic patients.
    Elizur A; Segal S; Yeret A; Ben-David M
    Isr Ann Psychiatr Relat Discip; 1979 Dec; 17(4):318-27. PubMed ID: 44877
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effect of propranolol, neuroleptics and their combination on serum prolactin levels of schizophrenic patients].
    Elizur A; Segal Z; Yeret A; Aboo-Shach M; Ben-David M
    Harefuah; 1979 Sep; 97(5-6):101-4. PubMed ID: 44254
    [No Abstract]   [Full Text] [Related]  

  • 5. Propranolol in schizophrenia. Clinical, metabolic, and pharmacological findings.
    Hanssen T; Heyden T; Sundberg I; Alfredsson G; Nybäck H; Wetterberg L
    Arch Gen Psychiatry; 1980 Jun; 37(6):685-90. PubMed ID: 7387339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of propranolol treatment on serum prolactin level in schizophrenic patients.
    Elizur A; Segal Z; Yeret A; Ben-David M
    Commun Psychopharmacol; 1980; 4(3):203-6. PubMed ID: 7226751
    [No Abstract]   [Full Text] [Related]  

  • 7. High-dose propranolol in schizophrenia.
    Sheppard GP
    Br J Psychiatry; 1979 May; 134():470-6. PubMed ID: 476356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decrease in serum-prolactin after propranolol in schizophrenia.
    Hanssen T; Heyden T; Sundberg I; Wetterberg L; Eneroth P
    Lancet; 1978 Jan; 1(8055):101-2. PubMed ID: 74547
    [No Abstract]   [Full Text] [Related]  

  • 9. Propranolol in schizophrenia. II. Clinical and biochemical aspects of combining propranolol with chlorpromazine.
    Peet M; Middlemiss DN; Yates RA
    Br J Psychiatry; 1981 Aug; 139():112-7. PubMed ID: 7030443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dextro-propranolol in schizophrenia.
    Hirsch SR; Manchanda R; Weller MP
    Prog Neuropsychopharmacol; 1980; 4(6):633-7. PubMed ID: 7220678
    [No Abstract]   [Full Text] [Related]  

  • 11. A dose-response study of propranolol in chronic schizophrenics.
    Gardos G; Cole JO; Volicer L; Orzack MH; Oliff AC
    Curr Ther Res Clin Exp; 1973 Jun; 15(6):314-23. PubMed ID: 4145858
    [No Abstract]   [Full Text] [Related]  

  • 12. Propranolol in schizophrenia.
    Sethi BB; Dubé S
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(1):89-99. PubMed ID: 6682990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations among plasma prolactin levels, tardive dyskinesia, and paranoia in treated schizophrenics: relevance to supersensitivity psychosis.
    Csernansky JG; Vinogradov S; Prosser E; Kaplan J; Berger PA; Hollister LE
    Psychopharmacol Bull; 1986; 22(3):897-9. PubMed ID: 2879311
    [No Abstract]   [Full Text] [Related]  

  • 14. [A double-blind study of metoclopramide in the treatment of schizophrenia and determination of prolactin].
    Gu SF
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Dec; 25(6):328-30, 382. PubMed ID: 1304992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsychotic effect of propranolol on chronic schizophrenics: study of a gradual treatment regimen.
    Elizur A; Segal Z; Yeret A; Davidson S; Atsmon A
    Psychopharmacology (Berl); 1979 Jan; 60(2):189-94. PubMed ID: 34185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction between superoxide dismutase and prolactin is involved in response to haloperidol and risperidone treatment in schizophrenia: a double-blind and randomized study.
    Zhang XY; Zhou DF; Cao LY; Wu GY; Shen YC
    J Clin Psychopharmacol; 2006 Feb; 26(1):103-5. PubMed ID: 16415724
    [No Abstract]   [Full Text] [Related]  

  • 17. Catechol-O-methyltransferase gene variants may associate with negative symptom response and plasma concentrations of prolactin in schizophrenia after amisulpride treatment.
    Chen CY; Yeh YW; Kuo SC; Ho PS; Liang CS; Yen CH; Lu RB; Huang SY
    Psychoneuroendocrinology; 2016 Mar; 65():67-75. PubMed ID: 26724569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum prolactin as a correlate of clinical response to haloperidol.
    Van Putten T; Marder SR; Mintz J
    J Clin Psychopharmacol; 1991 Dec; 11(6):357-61. PubMed ID: 1770154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin E1 treatment of schizophrenia.
    Kaiya H
    Biol Psychiatry; 1984 Mar; 19(3):457-63. PubMed ID: 6539131
    [No Abstract]   [Full Text] [Related]  

  • 20. Increased serum prolactin levels in drug-naive first-episode male patients with schizophrenia.
    Albayrak Y; Beyazyüz M; Beyazyüz E; Kuloğlu M
    Nord J Psychiatry; 2014 Jul; 68(5):341-6. PubMed ID: 24094029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.